LSBCF (LakeShore Biopharma Co) Total Operating Expense: $77.02 Mil (TTM As of Mar. 2025)


What is LakeShore Biopharma Co Total Operating Expense?

LakeShore Biopharma Co LSBCF Total Operating Expense is $77.02 Mil as of Mar. 2025. The stock has 5 warning signs investors should review.

LakeShore Biopharma Co's Total Operating Expense for the six months ended in Mar. 2025 was $38.50 Mil. LakeShore Biopharma Co's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was $77.02 Mil.

LakeShore Biopharma Co Total Operating Expense Related Terms

LakeShore Biopharma Co Total Operating Expense Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Total Operating Expense Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Total Operating Expense
49.10 74.45 92.66 100.46 76.10

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only 48.95 53.38 46.37 38.52 38.50

LakeShore Biopharma Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $77.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $77.02 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Total Operating Expense of $77.02 Mil as of Mar. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Total Operating Expense too high?
LakeShore Biopharma Co's current Total Operating Expense is $77.02 Mil.
How does LakeShore Biopharma Co's Total Operating Expense compare to ACUT and PPCB?
LakeShore Biopharma Co's Total Operating Expense of $77.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Total Operating Expense is $77.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Total Operating Expense of $77.02 Mil. The current Total Operating Expense is $77.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Total Operating Expense is $77.02 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.